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Synthetic Biology SelectIn this issue, Leading Edge highlights synthetic biology, a field that is deepening our understanding of the design princi-
ples of life and increasing our mastery of biological systems for practical applications in biotechnology and medicine.
Reports from the recent literature, discussed in this Synthetic Biology Select, include the rational design of a functional
enzyme, an approach for creating more stable proteins, and systems-level analyses that reveal unexpected sophistica-
tion in the regulatory networks of microorganisms.Overlay of the crystal structure of the rationally de-
signed protein (cyan) with the structure predicted
by computational modeling (yellow). Image cour-
tesy of Y. Lu.A How to Guide for Building an Enzyme
In a forceful demonstration of rational protein design, Yeung et al. (2009)
report the transformation of sperm whale myoglobin into a functional nitric
oxide reductase. Adding to the difficulty of this feat, crystal structures for
native nitric oxide reductases are currently lacking. Hence, the proposed
mechanism of catalysis had to be inferred from homology to subunits of
heme copper oxidases (such as cytochrome c oxidase). The authors’ efforts
ultimately entailed the introduction of three histidines and one glutamine to
create a non-heme binding site for iron, an essential cofactor for reductase
activity. This synthetic site is then shown to confer iron binding, and remark-
ably, the engineered protein acquires the ability to reduce nitric oxide (NO) to
nitrous oxide (N2O). When the designed protein is crystallized, the structure
of the rationally designed iron binding site closely matches the structure pre-
dicted by computational modeling. These findings show how synthetic
enzymes can provide insight into the mechanism of action of enzymes
and illustrate the power of in silico modeling for the design of synthetic
proteins.
N. Yeung et al. (2009). Nature. Published online November 25, 2009.
10.1038/nature08620.Tripartite fusion proteins in which a test protein is
inserted into the antibiotic resistance gene TEM1-
b-lactamase (b-lac) can be used to select for amino
acid substitutions that improve protein stability.
Figure courtesy of J. Bardwell.Selecting for Stability
Most amino acid substitutions decrease a protein’s stability. Given this
tendency, what tools do protein engineers have at their disposal when
enhanced stability is their goal? Recent work by Foit et al. (2009) provides
a clever means to select for improved stability through an in vivo screen in
the bacterium Escherichia coli. To do this, they insert a test protein between
the N- and C-terminal halves of TEM1-b-lactamase, an antibiotic resistance
protein. These tripartite fusion proteins are then expressed in E. coli and
grown in the presence of the antibiotic penicillin V, which TEM1-b-lactamase
counteracts. Using this system, the authors show for a collection of test
proteins that antibiotic resistance correlates with their stability. Taking this
a step further into the realm of protein engineering, the authors then test
a library of mutants for the protein Im7 (immunity protein 7) and succeed in
identifying mutations that improve Im7’s stability. However, these amino
acid substitutions come with an interesting side effect, in that many disrupt
the interaction of Im7 with the toxin colicin, its native interacting partner.
Thus, this approach offers a straightforward means to engineer a protein
with a desired stability and also reveals evidence of evolutionary tradeoffs
between function and stability. For in-depth discussion of the tradeoffs
involved in designing a different type of biological system—signal transduc-
tion pathways—see the Review in this issue by Christina Kiel, Eva Yus, and
Luis Serrano (page 33).
L. Foit et al. (2009). Mol. Cell 35, 861–871.How Yeast Know When It’s Time to Grow
It makes intuitive sense that the availability of energy, such as glucose, would be a primary determinant of a cell’s
growth rate. However, according to a recent examination by Youk and van Oudenaarden (2009), the growth landscape
for yeast is substantially more complex than anticipated. In yeast, glucose uptake is modulated by glucose sensors,
which promote the expression of six primary hexose transporters (HXT). Youk and van Oudenaarden decouple theCell 140, January 8, 2010 ª2010 Elsevier Inc. 5
sensing of extracellular glucose from its transport by deleting the endogenous HXT genes. They then replace the genes
one at a time and put them under the control of a promoter that is induced by doxycycline but not glucose. Surpris-
ingly, this decoupling reveals that an increase in the concentration of glucose does not invariably stimulate the rate of
yeast growth. In some cases, increasing the glucose concentration actually decreases the growth rate. Moreover, the
HXT replacement strains all behave differently with respect to the effect of glucose concentration on growth rate. Yet,
this is not to say that growth rate is unpredictable. By plotting all of the data together, the authors show that growth
rate is determined by two independent variables, the rate of glucose uptake and the extracellular concentration of
glucose, and that these variables can be fit into a relatively simple equation that defines a growth landscape. This anal-
ysis reveals the functional importance of the interaction between the modules that control glucose import and sensing.
By uncovering the underlying design principles controlling growth rate in yeast, this study may inform ongoing efforts to
engineer biological systems that respond dynamically to changing environmental conditions. The theme of engineering
dynamic control into heterologous pathways is explored in an Essay in this issue by William Holtz and Jay Keasling
(page 19).
H. Youk and A. van Oudenaarden (2009). Nature 462, 875–879.A cryo-electron tomogram of Mycoplasma pneu-
moniae. Image courtesy of A.-C. Gavin.Dissecting and Reconstructing Mycoplasma
Three recent studies (Ku¨hner et al., 2009; Yus et al., 2009; Gu¨ell et al.,
2009) suggest that the gene, protein, and metabolic networks of
Mycoplasma pneumoniae, a bacterium with one of the smallest known
genomes, display regulatory control previously thought to be limited to
eukaryotes. In the first paper, Ku¨hner et al. use mass spectrometry as
part of a genome-wide screen to define the protein complexes of
M. pneumoniae. This effort provides evidence that the organism has
200 protein complexes that form from among the organism’s
689 open reading frames. Building on existing structural data, the authors
then map some of the most prevalent proteins and complexes onto
cellular electron tomograms to produce a dramatic representation of
cellular organization. Yus et al. undertake the reconstruction of the meta-
bolic network of M. pneumoniae and use it to design a minimal culture
medium containing only 19 ingredients to support growth. Their study
further shows that M. pneumoniae has a greater capacity to adjust
gene expression in response to specific metabolic perturbations than
might be anticipated given that it is adapted to a specialized environmentand has very few transcription factors compared to more complex bacteria. The transcriptional dynamics of M. pneumo-
niae are examined in-depth by Gu¨ell et al. Their study reveals the existence of 341 operons, many of which display
production of alternate transcripts under different growth conditions. In addition, antisense transcripts are found in unan-
ticipated large numbers. The sophisticated way in which gene expression is regulated in M. pneumoniae indicates the
presence of underappreciated mechanisms that control gene expression, which when more completely understood might
be used in the engineering of microbial gene networks. (The use of transcriptional feedback mechanisms in the design of
cellular memory networks is discussed in this issue in an Essay on page 13 by Devin Burrill and Pamela Silver.) Cumu-
latively, these ambitious studies add new layers of insight into biological design and will undoubtedly provide food for
thought for those undertaking the construction of synthetic biological systems or contemplating the challenges of
creating synthetic organisms.
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